“…We recently reported that AR itself is an accessory protein associated with telomeres in prostate cancer cells; AR chromatin immunoprecipitate prepared using AR antibodies (AR-ChIP) contains telomeric DNA, telomeric chromatin isolated using a protocol called "proteomics of isolated chromatin" (PICh) (6) contains AR, and AR immunoprecipitates and colocalizes with telomeric proteins in LNCaP cells (3,4). A functional role of AR in telomere stability is indicated from the observations that (a) AR inactivation by androgen-depletion, treatment with antiandrogens such as bicalutamide (Casodex) or MDV3100 (Enzalutamide), or treatment with AR-siRNA results in telomere dysfunction, and (b) the synthetic androgen R1881 blocks androgen depletion-mediated telomere dysfunction (3,4).…”